NCT07662980

Brief Summary

The goal of this study is to measure the prevalence and risks of hyperglycemia in surgical patients with prediabetes. The main questions it aims to answer are:

  • What is the prevalence of hyperglycemia in surgical patients with prediabetes?
  • What is the relative risk of postoperative complications associated with hyperglycemia? To answer these questions, surgical patients with prediabetes will undergo universal glucose measurement in the perioperative period. Glucose data will be analyzed in conjunction with electronic health record (EHR) data describing patient outcomes.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
750

participants targeted

Target at P75+ for all trials

Timeline
12mo left

Started May 2027

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2026

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 23, 2026

Completed
10 months until next milestone

Study Start

First participant enrolled

May 1, 2027

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2028

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2028

Last Updated

June 23, 2026

Status Verified

February 1, 2026

Enrollment Period

1 year

First QC Date

February 23, 2026

Last Update Submit

June 17, 2026

Conditions

Keywords

PrediabetesPrevalenceSurgical ComplicationsPerioperative Hyperglycemia

Outcome Measures

Primary Outcomes (1)

  • Prevalence of perioperative hyperglycemia

    Prediabetes will be defined as described in Section 4.2 using Diabetes Canada definitions. The perioperative period will include the day of surgery and the early postoperative period. The day of surgery includes surgical admitting, intraoperative, and recovery room on postoperative day (POD) 0, which is the day that surgery was completed until 23:59. The early postoperative period will be defined as the first 3 full postoperative days, in keeping with studies that have demonstrated that hyperglycemia is most common in the first 72 hours after surgery and that early hyperglycemia is associated with greater 30-day postoperative mortality. Hyperglycemia will be defined using Diabetes Canada reference ranges as any glucose value \>10.0 mmol/L by any form of glucose measurement.

    Up to the first 3 postoperative days or discharge, whichever comes first.

Secondary Outcomes (1)

  • Post-operative complications

    Within 30 days of surgery.

Study Arms (1)

Surgical Patients with Prediabetes

Adult patients undergoing non-cardiac surgeries who have pre-diabetes.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Surgical in-patients at the Foothills Medical Centre.

You may qualify if:

  • Hemoglobin A1c measurement between 6 and 6.4%
  • Scheduled for non-cardiac surgery

You may not qualify if:

  • Age\>18
  • Pregnancy
  • Any formal diabetes diagnosis
  • Current use of medications that influence blood glucose regardless of the indication
  • Undergoing cardiac, intracranial neurosurgery, bariatric, or pancreatic surgeries

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foothills Medical Centre

Calgary, Alberta, Canada

Location

Related Publications (1)

  • Ruzycki SM, Harrison TG, Lithgow KC, Cameron A, Philp L, Heatlie L, Esmail R, Ejaredar M, Helmle K, McKeen J, Dillane D. Day-of-surgery quality gaps in glycemic management: a retrospective cohort study. Perioper Med (Lond). 2025 Nov 25;14(1):143. doi: 10.1186/s13741-025-00628-3.

    PMID: 41291884BACKGROUND

Related Links

MeSH Terms

Conditions

Prediabetic StateDiabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Shannon Ruzycki, MD

    University of Calgary

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
30 Days
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

February 23, 2026

First Posted

June 23, 2026

Study Start (Estimated)

May 1, 2027

Primary Completion (Estimated)

May 1, 2028

Study Completion (Estimated)

May 1, 2028

Last Updated

June 23, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will share

IPD, specifically deidentified patient data will be shared upon reasonable request by fellow research teams.

Shared Documents
STUDY PROTOCOL, SAP, ICF
Time Frame
Data will be available after analyses have completed, approximately in the month of March, 2028. Data will be retained in accordance with the University of Calgary's Master Records Retention Schedule(MaRRS). During this time period, data will be available upon reasonable request.

Locations